Company Filing History:
Years Active: 2005
Title: Innovations of Stanley L Lin in Tumor-Targeted Delivery
Introduction
Stanley L Lin is a notable inventor based in Madison, CT (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His focus on tumor-targeted delivery systems has the potential to revolutionize how solid tumors are treated.
Latest Patents
Stanley L Lin holds a patent titled "Compositions and methods for tumor-targeted delivery of effector molecules." This patent discloses the preparation and use of attenuated tumor-targeted bacteria vectors for delivering primary effector molecules directly to the site of solid tumors. The invention highlights the surprising discovery that these effector molecules, which can be toxic when administered systemically, can be delivered locally with reduced toxicity to the host. This method offers a promising approach to treating various solid tumor cancers, including carcinomas, melanomas, lymphomas, and sarcomas.
Career Highlights
Stanley L Lin is associated with Vion Pharmaceuticals, Inc., where he continues to advance his research in targeted cancer therapies. His work is characterized by a commitment to improving patient outcomes through innovative delivery methods.
Collaborations
Some of his notable coworkers include David Gordon Bermudes and Ivan C King, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Stanley L Lin's innovative work in tumor-targeted delivery systems represents a significant advancement in cancer treatment. His contributions have the potential to enhance the efficacy of therapies while minimizing side effects for patients.